))
Is the Longevity Field Overhyped? Charles Brenner—NAD Metabolomics Pioneer and Aging Realist
Manage episode 500137642 series 3659455
Shriya Bhat, Harvard BCI, Shriya Bhat, and Harvard BCI에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Shriya Bhat, Harvard BCI, Shriya Bhat, and Harvard BCI 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this episode, I talk to Charles Brenner, a leading biochemist and outspoken critic of hype in the longevity field. We discuss why many aging studies in model organisms don’t always translate to humans, the limitations of current NAD-related therapies, and how publication bias harms scientific progress. He also shares what excites him most right now—his lab’s work on citrin deficiency and its potential for treating fatty liver disease and metabolic disorders.Visit the Brenner Lab to learn more about their exciting work: https://www.cityofhope.org/research/riggs-institute/diabetes-and-cancer-metabolism/charles-brenner-lab https://brennerlab.netGoogle Scholar: https://scholar.google.com/citations?hl=en&user=XgEjtucAAAAJ&X: https://x.com/CharlesMBrenner
16 에피소드
공유
